Potential of Nanopore Long Read Sequencing for Determining CTG Repeat Lengths in the DMPK1 Gene During Prenatal or Preimplantation Genetic Testing
Prenatal Diagnosis · 2026
DOI: 10.1002/pd.70026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2026. Verfasst von Yui Shichiri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Aichi, Japan. Hauptthemen laut MEDLINE: Nanopore Sequencing, Preimplantation Diagnosis, Myotonin-Protein Kinase, Myotonic Dystrophy. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Objective
Myotonic dystrophy type 1 (DM1) is an autosomal dominant neurodevelopmental disorder caused by CTG repeat expansion in the DMPK gene. Although the clinical classification of DM1 is determined by the CTG repeat length in DMPK , conventional sizing relies on Southern blotting, which is a suboptimal method in prenatal and PGD contexts as it requires large amounts of genomic DNA. We here evaluated the utility of nanopore long read sequencing (LRS) for DM1 diagnosis in these contexts.
Method
LRS was performed with adaptive sampling or CRISPR/Cas9‐mediated enrichment targeting DMPK . The use of whole genome amplified DNA (WGA‐DNA) prepared with RepliG was also assessed.
Results
Adaptive sampling and Cas9‐based LRS enabled detection of both the normal and expanded alleles. Further, LRS with CRISPR/Cas9‐mediated enrichment improved efficiency and enabled accurate sizing of expanded CTG repeats exceeding 1000 units. In contrast, the use of whole genome amplified DNA prepared with RepliG did not permit reliable CTG repeat sizing, even when combined with adaptive sampling or CRISPR/Cas9.
Conclusion
Nanopore sequencing can potentially replace Southern blotting for prenatal DM1 diagnosis, including repeat sizing. However, further improvement is needed for PGD using WGA‐DNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Aichi, Japan.
- Department of Clinical Genetics, Fujita Health University Hospital, Aichi, Japan.
- Department of Medical Genetics and Genomics, Sapporo Medical University School of Medicine, Hokkaido, Japan.
- Open Facility Center and Oncology Innovation Center, Research Promotion Headquarters, Fujita Health University, Aichi, Japan.
- Department of Obstetrics and Gynecology, Fujita Health University School of Medicine, Aichi, Japan.
ORCID-Profile: Tasuku Mariya, Haruki Nishizawa, Hiroki Kurahashi
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Shichiri, Y., Inagaki, H., Mariya, T., Murase, Y., Sugimoto, T., Sugihara, E., Nishizawa, H., & Kurahashi, H. (2026). Potential of Nanopore Long Read Sequencing for Determining CTG Repeat Lengths in the DMPK1 Gene During Prenatal or Preimplantation Genetic Testing. Prenatal Diagnosis. https://doi.org/10.1002/pd.70026
Vancouver
Shichiri Y, Inagaki H, Mariya T, Murase Y, Sugimoto T, Sugihara E, et al. Potential of Nanopore Long Read Sequencing for Determining CTG Repeat Lengths in the DMPK1 Gene During Prenatal or Preimplantation Genetic Testing. Prenatal Diagnosis. 2026. doi:10.1002/pd.70026
BibTeX
@article{Shichiri2026,
author = {Shichiri, Yui and Inagaki, Hidehito and Mariya, Tasuku and Murase, Yuri and Sugimoto, Takeshi and Sugihara, Eiji and Nishizawa, Haruki and Kurahashi, Hiroki},
title = {Potential of Nanopore Long Read Sequencing for Determining CTG Repeat Lengths in the DMPK1 Gene During Prenatal or Preimplantation Genetic Testing},
journal = {Prenatal Diagnosis},
year = {2026},
doi = {10.1002/pd.70026}
}
EUVIMED